BMY vs MRK
Bristol Myers Squibb vs Merck & Co. — AI-powered side-by-side comparison
| Metric | BMY | MRK |
|---|---|---|
| AI Score | 70 | 59 |
| Price | $57.56 | $123.48 |
| P/E Ratio | 19.93× | 34.71× |
| ROE | 41.6% | 17.9% |
| Revenue Growth YoY | 1.8% | 2.9% |
| Gross Margin | 53.7% | 78.1% |
| Debt / Equity | 2.44× | 0.94× |
| Dividend Yield | 4.3% | 2.7% |
| RSI (14) | 53.8 | 45.9 |
| Beta | 0.235 | 0.21 |
| Expected Upside | +4.6% | +0.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
MRK Full Analysis